Design Therapeutics, Inc. · NASDAQ:DSGN
Sirenia Capital Management LP reported a 9.50% stake in Design Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Sirenia Capital Management LP reported a 9.50% stake in Design Therapeutics, Inc., 5,963,936 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.50%
- Shares
- 5,963,936
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sirenia Capital Management LP | 9.50% | 5,963,936 |
| Alex Silverstein | 9.50% | 5,963,936 |
Source
Related
- Design Therapeutics, Inc.
- Sirenia Capital Management LP
- Design Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jun 9, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13D/A · SR One Capital Fund I Aggregator, LP · Mar 11, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026